Fludarabine | List of Frontiers open access articles

Case Report

Published on 14 Nov 2023

Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairment

in Hematologic Malignancies

Franziska Marquard
Claudia Langebrake
Dietlinde Janson
Maida Mahmud
Adrin Dadkhah
Nicolaus Kröger
Francis Ayuk

Frontiers in Oncology

doi 10.3389/fonc.2023.1288764

3,694 views
6 citations

Original Research

Published on 14 Jun 2024

Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin’s lymphoma

in Cancer Immunity and Immunotherapy

David G. Frame
Marcus Geer
Salena Kasha
Denise Markstrom
Gianni Scappaticci
Tate Feeney
Andrew Hayduk
Hilary M. Mansoor
Avery Oberfeld
Hannah D’Antonio

Frontiers in Immunology

doi 10.3389/fimmu.2024.1403145

4,962 views
6 citations

Original Research

Published on 31 Mar 2017

Fludarabine Inhibits KV1.3 Currents in Human B Lymphocytes

in Pharmacology of Anti-Cancer Drugs

Alicia de la Cruz
Alba Vera-Zambrano
Diego A. Peraza
Carmen Valenzuela
Juan M. Zapata
Gema Perez-Chacon
Teresa Gonzalez

Frontiers in Pharmacology

doi 10.3389/fphar.2017.00177

4,173 views
5 citations

Perspective

Published on 22 Nov 2023

Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine?

in Cancer Immunity and Immunotherapy

Dimitrios Filioglou
Muhammad Husnain
Sharad Khurana
Richard J. Simpson
Emmanuel Katsanis

Frontiers in Immunology

doi 10.3389/fimmu.2023.1329850

4,457 views
6 citations

Original Research

Published on 25 Feb 2022

Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation

in Viral Immunology

Xiaoming Liu
Xiang Li
Ling Chen
Alan Chen-Yu Hsu
Kelly L. Asquith
Chi Liu
Karen Laurie
Ian Barr
Paul S. Foster
Ming Yang

Frontiers in Immunology

doi 10.3389/fimmu.2022.805558

5,755 views
5 citations

Review

Published on 07 Jan 2025

Current status and perspectives of hematopoietic cell transplantation in patients with paroxysmal nocturnal hemoglobinuria

in Alloimmunity and Transplantation

Marek Ussowicz
Dawid Przystupski
Patrycja Mensah-Glanowska
Agnieszka Piekarska

Frontiers in Immunology

doi 10.3389/fimmu.2024.1521484

6,709 views
1 citation

Mini Review

Published on 06 Mar 2023

Combining chemotherapy with CAR-T cell therapy in treating solid tumors

in Cancer Immunity and Immunotherapy

Arthur Xuan Wang
Xiao Jing Ong
Criselle D’Souza
Paul J. Neeson
Joe Jiang Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1140541

20,769 views
82 citations

Case Report

Published on 11 Apr 2024

Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review

in Hematologic Malignancies

Polina Bellman
Jesus D. Gonzalez-Lugo
Moazzam Shahzad
Muhammad Kashif Amin
Muhammad Fareed Khalid
Nahid Suleman
Nausheen Ahmed
Anurag K. Singh
Abdulraheem Yacoub
Da Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1383730

3,881 views
4 citations

Case Report

Published on 01 Jun 2022

Case Report: Chimeric Antigen Receptor T Cells Induced Late Severe Cytokine Release Syndrome

in Cancer Immunity and Immunotherapy

Jinping He
Na Xu
Hongsheng Zhou
Ya Zhou
Di Wu
Ruochong Zhao
Tong Lin
Ju Xu
Rui Cao
Peng Li

Frontiers in Oncology

doi 10.3389/fonc.2022.893928

5,484 views
5 citations

Mini Review

Published on 08 Feb 2022

Impact of Low-Burden TP53 Mutations in the Management of CLL

in Hematologic Malignancies

Gregory Lazarian
Florence Cymbalista
Fanny Baran-Marszak

Frontiers in Oncology

doi 10.3389/fonc.2022.841630

6,709 views
7 citations

Original Research

Accepted on 26 Jan 2026

In silico and in vitro investigation of the mechanisms of the drug-drug interaction between Fludarabine and Busulfan

in Drug Metabolism and Transport

Khalil Ben Hassine
Shannon Robin
Frederic Baleydier
Mourad Mseddi
Vid Mlakar
Jayaraman Muthukumaran
Marc Ansari
Chakradhara Rao Satyanarayana Uppugunduri

Frontiers in Pharmacology

212 views

Original Research

Published on 22 Mar 2022

Glycerophosphoinositol Promotes Apoptosis of Chronic Lymphocytic Leukemia Cells by Enhancing Bax Expression and Activation

in Molecular and Cellular Oncology

Gioia Boncompagni
Alessia Varone
Vanessa Tatangelo
Nagaja Capitani
Federica Frezzato
Andrea Visentin
Livio Trentin
Daniela Corda
Cosima T. Baldari
Laura Patrussi

Frontiers in Oncology

doi 10.3389/fonc.2022.835290

3,175 views
2 citations

Case Report

Published on 05 Dec 2024

Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis

in Hematologic Malignancies

Danqing Kong
Nana Ping
Qian Zhu
Xiao Zhang
Junhong Li
Rui Zou
Depei Wu
Zhengming Jin
Changju Qu

Frontiers in Oncology

doi 10.3389/fonc.2024.1491100

3,051 views

Original Research

Published on 03 Jul 2019

Dapagliflozin Attenuates Renal Tubulointerstitial Fibrosis Associated With Type 1 Diabetes by Regulating STAT1/TGFβ1 Signaling

in Clinical Diabetes

Fengjuan Huang
Yanyan Zhao
Qingzhu Wang
Jan-Luuk Hillebrands
Jacob van den Born
Linlin Ji
Tingting An
Guijun Qin

Frontiers in Endocrinology

doi 10.3389/fendo.2019.00441

9,922 views
70 citations

Case Report

Published on 30 Jun 2017

Hematopoietic Stem Cell Transplantation in an Infant with Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome

in Primary Immunodeficiencies

Katharina L. Gössling
Cyrill Schipp
Ute Fischer
Florian Babor
Gerhard Koch
Friedhelm R. Schuster
Jutta Dietzel-Dahmen
Dagmar Wieczorek
Arndt Borkhardt
Roland Meisel

Frontiers in Immunology

doi 10.3389/fimmu.2017.00773

7,391 views
18 citations

Clinical Trial

Published on 21 Jun 2021

First-in-Human Trial of EphA2-Redirected CAR T-Cells in Patients With Recurrent Glioblastoma: A Preliminary Report of Three Cases at the Starting Dose

in Cancer Immunity and Immunotherapy

Qingtang Lin
Teer Ba
Jinyuan Ho
Dandan Chen
Ye Cheng
Leiming Wang
Geng Xu
Lixin Xu
Yiqiang Zhou
Yukui Wei

Frontiers in Oncology

doi 10.3389/fonc.2021.694941

12,631 views
95 citations

Articles

Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairment

Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin’s lymphoma

Fludarabine Inhibits KV1.3 Currents in Human B Lymphocytes

Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine?

Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation

Current status and perspectives of hematopoietic cell transplantation in patients with paroxysmal nocturnal hemoglobinuria

Combining chemotherapy with CAR-T cell therapy in treating solid tumors

Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review

Case Report: Chimeric Antigen Receptor T Cells Induced Late Severe Cytokine Release Syndrome

Impact of Low-Burden TP53 Mutations in the Management of CLL

In silico and in vitro investigation of the mechanisms of the drug-drug interaction between Fludarabine and Busulfan

Glycerophosphoinositol Promotes Apoptosis of Chronic Lymphocytic Leukemia Cells by Enhancing Bax Expression and Activation

Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis

Dapagliflozin Attenuates Renal Tubulointerstitial Fibrosis Associated With Type 1 Diabetes by Regulating STAT1/TGFβ1 Signaling

Hematopoietic Stem Cell Transplantation in an Infant with Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome

First-in-Human Trial of EphA2-Redirected CAR T-Cells in Patients With Recurrent Glioblastoma: A Preliminary Report of Three Cases at the Starting Dose